Digitalization of Russian Biobanks for Medical Genetic Studies: Problems and Prospects
https://doi.org/10.25557/2073-7998.2023.05.12-21
Abstract
Today, genetic technologies and biobanking form the basis for the development of personalized medicine. At the same time, the collection, storage, analysis and dissemination of biological samples and associated data are both the basis for current and future research, and strategically important information at the state level. To ensure the safety and information security of such information, it is important to build a state information system with a focus on the best world analogues but using import-independent technologies. The article analyzes the foreign experience of digitalization of biobanks and identifies the key advantages of existing information systems, provides examples of the use of collections and data in the implementation of medical genetics tasks, and suggests a step-by-step path for the development of genetic informatization with adaptation to Russian realities, problems, and tasks.
Supporting agencies: The study was supported by Project No. 15.BRK.21.008 “Multicenter Research Bioresource Collection “Human Reproductive Health” (Agreement No. 075-15-2021-1058 dated 09.28.2021), funded by the Ministry of Science and Higher Education of the Russian Federation.
About the Authors
A. S. Glotov
D.O. Ott Research Institute of Obstetrics, Gynecology and Reproductology
Russian Federation
Russian Federation
3, Mendeleevskaya line, Saint Petersburg, 199034
O. Yu. Yartseva
LtD “Genome Expert”
Russian Federation
Russian Federation
57/2, Dubininskaya st., Moscow, 115054
Yu. A. Nasykhova
D.O. Ott Research Institute of Obstetrics, Gynecology and Reproductology
Russian Federation
Russian Federation
3, Mendeleevskaya line, Saint Petersburg, 199034
T. E. Lazareva
D.O. Ott Research Institute of Obstetrics, Gynecology and Reproductology; LtD “Genome Expert”
Russian Federation
Russian Federation
3, Mendeleevskaya line, Saint Petersburg, 199034
57/2, Dubininskaya st., Moscow, 115054
Yu. A. Barbitov
D.O. Ott Research Institute of Obstetrics, Gynecology and Reproductology
Russian Federation
Russian Federation
3, Mendeleevskaya line, Saint Petersburg, 199034
A. D. Martynov
Association of Biomedical Cell Products Manufacturers
Russian Federation
Russian Federation
14, Krutitskiy val, Moscow, 109044
T. M. Akhmerov
LtD “Genome Expert”
Russian Federation
Russian Federation
57/2, Dubininskaya st., Moscow, 115054
References
1. Mikhailova A.A., Nasykhova Yu.A., Muravyov A.I., Efimenko A.Yu., Glotov A.S. Na puti k sozdaniyu obshchego glossariya biobankov Rossiyskoy Federatsii [Towards the creation of a unified glossary of Russian biobanks]. Kardiovaskulyarnaya terapiya i profilaktika [Cardiovascular Therapy and Prevention]. 2020;19(6):2710. (In Russ.)
2. Cambon-Thomsen A., Ducournau P., Gourraud P.A., Pontille, D. Biobanks for Genomics and Genomics for Biobanks. Comp. Funct. Genom. 2003; 4: 628–634.
3. Lazareva T.E., Barbitoff Y.A., Changalidis A.I., Tkachenko A.A., Maksiutenko E.M., Nasykhova Y.A., Glotov A.S. Biobanking as a Tool for Genomic Research: From Allele Frequencies to Cross-Ancestry Association Studies. Journal of Personalized Medicine. 2022; 12(12):2040
4. Kawame H., Fukushima A., Fuse N., Nagami F., Suzuki Y., Sakurai-Yageta M., Yasuda J., Yamaguchi-Kabata Y., Kinoshita K., Ogishima S., et al. The return of individual genomic results to research participants: Design and pilot study of Tohoku Medical Megabank Project. J. Hum. Genet. 2022; 67: 9–17.
5. Alver M., Palover M., Saar A., Läll K., Zekavat S.M., Tõnisson N., Leitsalu L., Reigo A., Nikopensius T., Ainla T., et al. Recall by genotype and cascade screening for familial hypercholesterolemia in a population-based biobank from Estonia. Genet. Med. 2019; 21: 1173–1180.
6. All of Us Research Program Investigators, Denny J.C., Rutter J.L., Goldstein D.B., Philippakis A., Smoller J.W., Jenkins G., Dishman, E. The “All of Us” Research Program. N. Engl. J. Med. 2019; 381: 668–676.
7. Grant M., Maytum J. P. What will follow the first hundred thousand genomes in the NHS? Personalized Medicine. 2018; 15(4):239-241.
8. Van Hout C.V., Tachmazidou I., Backman J.D., Hoffman J.D., Liu D., Pandey A.K., Gonzaga-Jauregui C., Khalid S., Ye B., Banerjee N., et al. Exome sequencing and characterization of 49,960 individuals in the UK Biobank. Nature. 2020; 586: 749–756.
9. Ishigaki K., Akiyama M., Kanai M., Takahashi A., Kawakami E., Sugishita H., Sakaue S., Matoba N., Low S.K., Okada Y., et al. Large-scale genome-wide association study in a Japanese population identifies novel susceptibility loci across different diseases. Nat. Genet. 2020; 52: 669–679.
10. Locke A.E., Steinberg K.M., Chiang C.W.K., Service S.K., Havulinna A.S., Stell L., Pirinen M., Abel H.J., Chiang C.C., Fulton R.S., et al. Exome sequencing of Finnish isolates enhances rare-variant association power. Nature. 2019; 572: 323–328
11. Biobankirovaniye. Natsional’noye rukovodstvo [Biobanking. National guidance]. Anisimov S. V., Akhmerov T. M., Balanovsky O. P. and others; National Association of Biobanks and Biobanking Professionals. – Moskva : OOO «Izdatel’stvo TRIUMF» [Moscow: TRIUMPH Publishing House LLC], 2022. – 308 p. (In Russ.)
Review
For citations:
Glotov A.S., Yartseva O.Yu., Nasykhova Yu.A., Lazareva T.E., Barbitov Yu.A., Martynov A.D., Akhmerov T.M. Digitalization of Russian Biobanks for Medical Genetic Studies: Problems and Prospects. Medical Genetics. 2023;22(5):12-21. (In Russ.) https://doi.org/10.25557/2073-7998.2023.05.12-21
Views:
335
Email this article 